TZIELD® (teplizumab-mzwv) is the first and only FDA approved treatment indicated to delay the onset of Stage 3 Type 1 Diabetes for people 8 years and older who have Stage 2 Type 1 …

TZIELD is a prescription medicine used to delay the onset of Stage 3 type 1 diabetes, which is when your body can’t make enough insulin on its own and may require insulin injections. …

TZIELD is a prescription medicine used to delay the onset of Stage 3 type 1 diabetes, which is when your body can’t make enough insulin on its own and may require insulin injections. …

TZIELD is a prescription medicine used to delay the onset of Stage 3 type 1 diabetes, which is when your body can’t make enough insulin on its own and may require insulin injections. …

What is TZIELD? TZIELD is a prescription medicine used to delay the onset of Stage 3 type 1 diabetes, which is when your body can’t make enough insulin on its own and may require …

TZIELD is a prescription medicine used to delay the onset of Stage 3 type 1 diabetes, which is when your body can’t make enough insulin on its own and may require insulin injections. …

Learn more about how TZIELD® (teplizumab-mzwv) works differently and how it can help the body produce its own insulin for longer.

See TZIELD® (teplizumab-mzwv) dosing and administration information. TZIELD® is an intravenous (IV) infusion given once a day for 14 days in a row.

There's a lot to say about type 1 diabetes (T1D) and TZIELD. If you'd prefer a more bite-sized view of T1D, including understanding how to spot T1D early, the importance of early screening …

301 Moved Permanently. CloudFront